ArticleACS medicinal chemistry letters2022

Discovery and Characterization of a Novel Series of Chloropyrimidines as Covalent Inhibitors of the Kinase MSK1.

Adrian Hall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.